W

Western States Clinical Research, Inc. | Wheat Ridge, CO

Research site

(Unclaimed)

Location

4251 Kipling Street Suite 540, Wheat Ridge, Colorado, United States of America

Site insights

Top conditions

Top treatments

Vonoprazan

APT-1011

Lansoprazole

UPB-101

Cenicriviroc

CC-93538

Lebrikizumab

Indacaterol

Linaclotide

prostacyclin

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

4 of 26 total trials

A Phase 3 Study of Barzolvolimab in Participants with Chronic Spontaneous Urticaria (EMBARQ-CSU1)

The purpose of this study is to establish the efficacy, safety and tolerability of barzolvolimab in adult participants with Chronic Spontaneous Urtic...

Enrolling

Chronic Spontaneous Urticaria

Biological: barzolvolimab

Biological: Matching placebo

A Study to Investigate the Efficacy and Safety of Verekitug (UPB-101) in Participants with Chronic Rhinosinusitis with Nasal Polyps (VIBRANT)

The primary purpose of this study is to assess the effect of verekitug (UPB-101) on the endoscopically determined size and extend of nasal polyps in...

Enrolling

Chronic Rhinosinusitis with Nasal Polyps

Drug: Placebo

Drug: Verekitug (UPB-101)

Dose Ranging Study of Lunsekimig Compared With Placebo-control in Adult Participants With Moderate-to-severe Asthma (AIRCULES)

This is a Phase 2b, global, multicenter, randomized, double-blind, placebo-controlled, parallel group, dose ranging study to assess the efficacy, saf...

Enrolling

Asthma

Drug: Placebo

Drug: Lunsekimig

Safety Study of CC-93538 in Adult and Adolescent Participants With Eosinophilic Esophagitis

This study is an open-label, uncontrolled study design to evaluate the long-term safety and tolerability of treatment with CC-93538. The study will e...

Active, not recruiting

Eosinophilic Esophagitis

Drug: CC-93538